FOSTER CITY, Calif. -- Sept. 29, 2021-- Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a leader in rare liver disease, today announced that the U.S. Food and Drug Administration (FDA) has approved...
Sean McCarthy is participating in a panel at the Financing Solutions and Strategies for Life Sciences Conference in New York City
News | 10. 19. 2009
© 2021 Pappas Capital, LLC. ALL RIGHTS RESERVED.